Literature DB >> 8013753

Non-insulin-mediated glucose disappearance in subjects with IDDM. Discordance between experimental results and minimal model analysis.

M J Quon1, C Cochran, S I Taylor, R C Eastman.   

Abstract

Both insulin and glucose contribute to the regulation of glucose metabolism in vivo. We directly measured the ability of glucose per se to promote glucose disposal in subjects with insulin-dependent diabetes mellitus (IDDM). We compared our results with predictions of the minimal model of glucose metabolism. To identify minimal model parameters, a frequently sampled intravenous glucose tolerance test (FSIVGTT) was administered to each subject while they were connected to a Biostator (a device that monitors blood glucose and gives insulin to mimic normal insulin secretion). Data from this test reflected normal glucose tolerance and were in excellent agreement with minimal model predictions. The FSIVGTT was then repeated without the Biostator in the same diabetic subjects in order to directly measure the effect of glucose per se to promote glucose disposal in the absence of an incremental insulin effect (a basal insulin drip was maintained). To compare these results with minimal model predictions, the equations describing glucose disappearance in the absence of an incremental insulin effect were solved using parameters identified from the Biostator experiment. The glucose disappearance measured in the absence of an incremental insulin response was much slower than the minimal model predictions. Thus, the minimal model appears to overestimate the effect of glucose per se on glucose uptake and underestimate the contribution of incremental insulin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8013753     DOI: 10.2337/diab.43.7.890

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  15 in total

Review 1.  The future of open- and closed-loop insulin delivery systems.

Authors:  Terry G Farmer; Thomas F Edgar; Nicholas A Peppas
Journal:  J Pharm Pharmacol       Date:  2008-01       Impact factor: 3.765

2.  A closed-loop artificial pancreas using a proportional integral derivative with double phase lead controller based on a new nonlinear model of glucose metabolism.

Authors:  Ilham Ben Abbes; Pierre-Yves Richard; Marie-Anne Lefebvre; Isabelle Guilhem; Jean-Yves Poirier
Journal:  J Diabetes Sci Technol       Date:  2013-05-01

3.  Is the minimal model too minimal?

Authors:  A Caumo; P Vicini; C Cobelli
Journal:  Diabetologia       Date:  1996-08       Impact factor: 10.122

4.  Standardized Mixed-Meal Tolerance and Arginine Stimulation Tests Provide Reproducible and Complementary Measures of β-Cell Function: Results From the Foundation for the National Institutes of Health Biomarkers Consortium Investigative Series.

Authors:  Sudha S Shankar; Adrian Vella; Ralph H Raymond; Myrlene A Staten; Roberto A Calle; Richard N Bergman; Charlie Cao; Danny Chen; Claudio Cobelli; Chiara Dalla Man; Mark Deeg; Jennifer Q Dong; Douglas S Lee; David Polidori; R Paul Robertson; Hartmut Ruetten; Darko Stefanovski; Maria T Vassileva; Gordon C Weir; David A Fryburg
Journal:  Diabetes Care       Date:  2016-07-12       Impact factor: 19.112

5.  A novel hierarchal-based approach to measure insulin sensitivity and secretion in at-risk populations.

Authors:  Paul D Docherty; J Geoffrey Chase; Lisa Te Morenga; Liam M Fisk
Journal:  J Diabetes Sci Technol       Date:  2014-05-26

6.  Design and clinical pilot testing of the model-based dynamic insulin sensitivity and secretion test (DISST).

Authors:  Thomas F Lotz; J Geoffrey Chase; Kirsten A McAuley; Geoffrey M Shaw; Paul D Docherty; Juliet E Berkeley; Sheila M Williams; Christopher E Hann; Jim I Mann
Journal:  J Diabetes Sci Technol       Date:  2010-11-01

7.  Population pharmacodynamic modeling of hyperglycemic clamp and meal tolerance tests in patients with type 2 diabetes mellitus.

Authors:  Ying Hong; Jasper Dingemanse; Patricia Sidharta; Donald E Mager
Journal:  AAPS J       Date:  2013-08-01       Impact factor: 4.009

Review 8.  The forgotten role of glucose effectiveness in the regulation of glucose tolerance.

Authors:  Simmi Dube; Isabel Errazuriz-Cruzat; Ananda Basu; Rita Basu
Journal:  Curr Diab Rep       Date:  2015-06       Impact factor: 4.810

Review 9.  Systems engineering medicine: engineering the inflammation response to infectious and traumatic challenges.

Authors:  Robert S Parker; Gilles Clermont
Journal:  J R Soc Interface       Date:  2010-02-10       Impact factor: 4.118

10.  Pancreatic network control of glucagon secretion and counterregulation.

Authors:  Leon S Farhy; Anthony L McCall
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.